ARCHIVES

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

Comprehensive Center NCAB Evaluations

June 2, 1978

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

Simone Retires From Academic Medicine, But Plans To Remain Active In Advisory Roles.

September 7, 2001

In Brief: Ruddon To Head Eppley Institute; Shapiro elected ACR President; ACR Medalists Named

November 3, 1989

Women Who Received CMF Chemotherapy Score Lower On Cognitive Skill Exams

March 30, 2012

HCFA Draft Document Dampens Jubilation Over Clinton Plan To Pay Patient Care Costs.

June 16, 2000